Tumours Flashcards

1
Q

5 year recurrence rates of meningiomas based upon Simpson grading

A

10% for grade 1
20% for grade 2
30% for grade 3
40% for grade 4.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Origin of lateral ventricle meningiomas

A

arachnoid cap cells, also located in choroid plexus.

During embryology, the meningocytes also migrate with choroid plexus, therefore meningiomas can arise from choroid plexus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Prognosis of IDH-wt GBM with GTR vs subtotal resection

A

41% PFS at 6 months vs
21%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Overall survival of patients with MGMT methylation vs those without MGMT methylation

A

MGMT methylation: 24 months
no MGMT methylation: 12 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Histological subtypes of medulloblastomas

A

CDE A

Classic
Desmoplastic/nodular
Extensive nodularity
Anaplastic/large cell (this would be classified as high risk)

Desmoplastic has best prognosis, most likely to occur in older children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Locations of different types of medulloblastomas.

A

wnt activated tumours develop from WNT expressing cells in the lower rhombic lip.
These tumours are more likely to be located in the cerebellar peduncle/CPA.
SHH – develop from SHH modulated cerebellar cortex. More likely hemispheric.
Group 3 and 4 origin is unclear. But more likely to be located in the fourth ventricle.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Features of high risk medulloblastoma, over standard risk

A

Less than 3y/o
Residual of more than 1.5cm3
Mets

C-myc amplification
>3y/o with anaplastic histology

40% PFS at 5 years with high risk medulloblastomas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Standard risk medulloblastoma treatment and prognosis

A

craniospinal irradiation (23.4Gy) within 40days of a surgery. Post fossa boost of 55Gf), with concurrent PACKER regime chemotherapy. Once weekly, cisplastin, vincristine, CCNU. 5 year PFS of 80%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Radiosensitive brain tumours

A

Germinomas, NGGCT
Medulloblastomas and PNETs
DNET
ATRT
Choroid plexus carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ATRT

A

rhabdoid cells (rod-shaped)
eosinophilic cytoplasm.

Rapid growth, therefore can present with macrocephaly in babies.

Median survival 17 months. (1 year old, death by knife)

Sometimes present with macrocephaly, under 2y/o.
If less than 3 years old, 15% of malignant brain tumours is ATRT, and half arise from post fossa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

New feature about astrocytomas in 2021 WHO tumour guidelines

A

IDH-1 GBM are now classified as grade 4 astrocytomas.

Grade 4 astrocytomas are differentiated from Grades 2 and 3 by the presence of CDKNA2A/B deletion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does ATRX do

A

deposits histones at telomeres. Reduced ATRX (ie. ATRX loss) is associated with longer telomeres, a feature of many cancers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diagnostic features of grade 4 astrocytomas

A

Necrosis on histology
Or
CDKNA2A/B deleted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Low vs high copy number variation of CDKNA2A/B, vs deleted CDKNA2A/B

A

Low = low grade
High = higher grade astrocytoma
Deleted = grade 4 astrocytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is mutually exclusive from IDH in GBM

A

TERT

If TERT is present in GBM, most likely wild type.
If IDH present in GBM, most likely high grade astrocytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

5 year survival for juvenile pilocytic astrocytomas, according to extent of resection

A

GTR: >90% 5 year survival
subtotal resection: 50% 5 year survival.

17
Q

What to do with residual pilocytic astrocytoma tumour

A

See whether can resect more
Active surveillance
Redo resection if there is regrowth
SRS

18
Q
A
19
Q

New drug in treatment of IDH gliomas

A

Vorasidenib.
IDH inhibitor, prevents accumulation of 2HG that leads do tumour growth and progression..

Given in residual or recurrent grade 2 IDHmutant gliomas

Improves radiological PFS from 11 to 28 months

Higher adverse events in vorasidenib group, raised ALT, but was reversible

20
Q

What is Ki67

A

Proliferative index.
A protein which is present during all active phases of the cell cycle, but not G0

21
Q

Colloid cyst risk score

A

5 points in total, yes and no

<2 is low risk. >4 is high risk of hydrocephalus

Risk zone = anterior to mammillary bodies or behind aqueduct